NASDAQ: IDXX · Life Sciences · 6 alerts · CIK 874716
Share price
$700.65Close, Nov 16
Market cap
$55.2B
Shares outstanding
78.79MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Idexx Laboratories Inc filings on SEC EDGAR ↗
Idexx Laboratories Executive Chair of the Board Jonathan Jay Mazelsky Sells $17.7M of Stock
Jonathan Jay Mazelsky, Executive Chair of the Board, sold 25,140 shares of Idexx Laboratories Inc at $698.26 to $711.95 a share (average $703.19) in 13 transactions, worth $17.7M in total on Nov 4, 2026. Shares held after the trade: 83,803 (-0.4%).
Idexx Laboratories EVP Michael Lane Sells $2.74M of Stock
Michael Lane, EVP, sold 3,979 shares of Idexx Laboratories Inc at $687.46 to $689.70 a share (average $688.64) in 3 transactions, worth $2.74M in total on Nov 4, 2026. Shares held after the trade: 4,076 (-29.2%).
Idexx Laboratories EVP, GC & Corporate Secretary Sharon E. Underberg Sells $6.13M of Stock
Sharon E. Underberg, EVP, GC & Corporate Secretary, sold 8,906 shares of Idexx Laboratories Inc at $688.25 to $690.02 a share (average $688.59) in 3 transactions, worth $6.13M in total on Nov 4, 2026. Shares held after the trade: 7,169 (-12.8%).
Idexx Laboratories Insider Daniel M. Junius Sells $845K of Stock
Daniel M. Junius sold 1,200 shares of Idexx Laboratories Inc at $701.68 to $705.78 a share (average $704.07) in 2 transactions, worth $845K in total on Nov 4, 2026. Shares held after the trade: 2,361 (-17.5%).